Citi Resumes Tenet Healthcare (THC) at Buy
Citi analyst Ralph Giacobbe resumes coverage on Tenet Healthcare (NYSE: THC) with a Buy rating.
For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.
Shares of Tenet Healthcare closed at $70.00 yesterday.
